Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Ottawa

$105,000.00

Molecular pathophysiology and stem cell treatment for mitochondrial diseases: insights from the French Canadian variant of Leigh Syndrome

FY 2017-18

Summary
Mitochondria are structures within our cells that are responsible, among other things, for the production of energy. Genetic Mitochondrial Diseases affect the proper functioning of mitochondria. Organs with high-energy demand, such as muscles, heart and brain, are more susceptible and become dysfunctional. Symptoms appear either early in childhood or later in adulthood, and vary greatly from one person to another making diagnosis a challenge. Approximately 1/4000 child is suffering of a mitochondrial disease and among mitochondrial diseases Leigh Syndrome is the most common presentation. The French Canadian Variant of Leigh Syndrome (LSFC) affects 1/2000 child in the Saguenay-Lac-Saint-Jean region of Quebec and there is no available cure to treat them. Recently, many studies revealed the multiple beneficial effects of stem cell. After a single injection, stem cells circulate in the body and home in the affected organ to heal it. Stem cells are currently used in clinical trials in humans to treat various diseases and we think they are an interesting option for the treatment of mitochondrial disorders. To better understand the mechanisms underlying mitochondrial diseases, our research group has developed a genetically modified mouse mimicking LSFC. The goal of this project is to study how the proper functioning of the mitochondria is altered in a model of LSFC. Afterwards, we will treat the LSFC mouse with stem cells collected from healthy mice. We will repeat our previous measurements to validate how this treatment improves the outcome of mitochondrial diseases. Our work will greatly contribute to the knowledge on mitochondrial disease, help with diagnosis and patient care, and potentially propose a curative therapy for patients.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
383302
Name
Cuillerier Alexanne
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Molecular pathophysiology and stem cell treatment for mitochondrial diseases: insights from the French Canadian variant of Leigh Syndrome
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Bioenergetics; Genetic Mitochondrial Diseases; Leigh Syndrome; Liver; Lrpprc; Mesenchymal Stem Cells; Mitochondria; Mitochondrial Dysfunctions; Physiology; Stem Cell Therapy
Abstract
Mitochondria are structures within our cells that are responsible, among other things, for the production of energy. Genetic Mitochondrial Diseases affect the proper functioning of mitochondria. Organs with high-energy demand, such as muscles, heart and brain, are more susceptible and become dysfunctional. Symptoms appear either early in childhood or later in adulthood, and vary greatly from one person to another making diagnosis a challenge. Approximately 1/4000 child is suffering of a mitochondrial disease and among mitochondrial diseases Leigh Syndrome is the most common presentation. The French Canadian Variant of Leigh Syndrome (LSFC) affects 1/2000 child in the Saguenay-Lac-Saint-Jean region of Quebec and there is no available cure to treat them. Recently, many studies revealed the multiple beneficial effects of stem cell. After a single injection, stem cells circulate in the body and home in the affected organ to heal it. Stem cells are currently used in clinical trials in humans to treat various diseases and we think they are an interesting option for the treatment of mitochondrial disorders. To better understand the mechanisms underlying mitochondrial diseases, our research group has developed a genetically modified mouse mimicking LSFC. The goal of this project is to study how the proper functioning of the mitochondria is altered in a model of LSFC. Afterwards, we will treat the LSFC mouse with stem cells collected from healthy mice. We will repeat our previous measurements to validate how this treatment improves the outcome of mitochondrial diseases. Our work will greatly contribute to the knowledge on mitochondrial disease, help with diagnosis and patient care, and potentially propose a curative therapy for patients.
Competitiondate
201710
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Cuillerier, Alexanne
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
University of Ottawa - $105,000 Grant (2017-18) | Canada Spends